Bubiket Study: Ultrasound Guided Fascia Iliaca Nerve Block With Bupivacaine and Adjuvant Ketamine vs. Bupivacaine Alone
Status:
Withdrawn
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The project is meant to evaluate the effect of a combination of medications (Bupivacaine +
Ketamine) used in an ultra-sound guided nerve block for patients presenting to the Emergency
Department (ED) with hip and/or femur fractures. The goal is to see whether the combination
of these two medications will result in greater and longer-lasting pain relief,
longer-lasting motor and sensory block and overall less need for opioid rescue analgesia.